InspireMD, Inc. (NSPR)

Market Cap	74.44M
Revenue (ttm)	7.03M
Net Income (ttm)	-36.14M
Shares Out	30.64M
EPS (ttm)	-0.79
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	83,840
Open	2.270
Previous Close	2.430
Day's Range	2.270 - 2.480
52-Week Range	1.990 - 3.798
Beta	0.57
Analysts	Strong Buy
Price Target	4.50 (+82.93%)
Earnings Date	Aug 5, 2025

About NSPR

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 86
• Stock Exchange: NASDAQ
• Ticker Symbol: NSPR
• Website: https://www.inspiremd.com

Financial Performance

In 2024, InspireMD's revenue was $7.01 million, an increase of 12.96% compared to the previous year's $6.21 million. Losses were -$32.01 million, 60.7% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for NSPR stock is "Strong Buy." The 12-month stock price target is $4.5, which is an increase of 82.93% from the latest price.

Price Target

$4.5

(82.93% upside)

Analyst Consensus: Strong Buy